Editorials

Prostate cancer and deprivation

BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2043 (Published 22 April 2010) Cite this as: BMJ 2010;340:c2043
  1. Kari A O Tikkinen, urology resident1,
  2. Anssi Auvinen, professor of epidemiology2
  1. 1Department of Urology and Clinical Research Institute HUCH Ltd, Helsinki University Central Hospital, Haartmaninkatu 4/Tutkijatilat H3011, PO Box 105, 00029 Helsinki, Finland
  2. 2Tampere School of Public Health, University of Tampere, 33014 Tampere, Finland
  1. kari.tikkinen{at}fimnet.fi

    Less radical treatment corresponds with higher deprivation, but the effect on survival differences is unclear

    The Alma-Ata Declaration of 1978 states: “The existing gross inequality in the health status of the people particularly between developed and developing countries, as well as within countries is politically, socially and economically unacceptable and is, therefore, of common concern to all countries.”1 Many studies have shown large disparities in the burden of cancer according to race or ethnicity and socioeconomic status. Indeed, socioeconomic factors such as poverty, inadequate education, and lack of health insurance are more important determinants than biological differences.2 3 In the linked study (doi:10.1136/bmj.c1928), Lyratzopoulos and colleagues use a population based cancer registry to assess variations in the management of prostate cancer in patients of different socioeconomic status.4

    Prostate cancer is the most common non-cutaneous cancer in men in most industrialised countries. Stage at diagnosis and mode of treatment are the main determinants of the outcome for most cancers.5 Differences in survival from prostate cancer …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe